PathVar : A Customisable NGS Variant Calling Algorithm Implicates Novel Candidate Genes and Pathways in Hemiplegic Migraine
Clinical Genetics · 2025
DOI: 10.1111/cge.14625 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, 2025. Verfasst von Mohammed M Alfayyadh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Genomics and Personalised Health, Genomics Research Centre, School of Biomedical Sciences, Queensland University of Technology (QUT), Bris…. Hauptthemen laut MEDLINE: Algorithms, High-Throughput Nucleotide Sequencing, Genetic Predisposition to Disease, Migraine with Aura. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Queensland University of Technology Postgraduate Research Award (QUTPRA), Australian National Health and Medical Research Council, Migraine Research Foundation.
Abstract (Originalsprache)
The exponential growth of next‐generation sequencing (NGS) data requires innovative bioinformatics approaches to unravel the genetic underpinnings of diseases. Hemiplegic migraine (HM), a debilitating neurological disorder with a genetic basis, is one such condition that warrants further investigation. Notably, the genetic heterogeneity of HM is underscored by the fact that approximately two‐thirds of patients lack pathogenic variants in the known causal ion channel genes. In this context, we have developed PathVar, a novel bioinformatics algorithm that harnesses publicly available tools and software for pathogenic variant discovery in NGS data. PathVar integrates a suite of tools, including HaplotypeCaller from the Genome Analysis Toolkit (GATK) for variant calling, Variant Effect Predictor (VEP) and ANNOVAR for variant annotation, and TAPES for assigning the American College of Medical Genetics and Genomics (ACMG) pathogenicity labels. Applying PathVar to whole exome sequencing data from 184 HM patients, we detected 648 variants that are probably pathogenic in multiple patients. Moreover, we have identified several candidate genes for HM, many of which cluster around the Rho GTPases pathway. Future research can leverage PathVar to generate high quality, candidate pathogenic variants, which may enhance our understanding of HM and other complex diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Genomics and Personalised Health, Genomics Research Centre, School of Biomedical Sciences, Queensland University of Technology (QUT), Brisbane, Australia.
Förderung
- Queensland University of Technology Postgraduate Research Award (QUTPRA)
- Australian National Health and Medical Research Council
- Migraine Research Foundation
- Australian International Science Linkages
- Australian Government EIF Super Science Funds
- Queensland University of Technology
Zitieren
APA
Alfayyadh, M. M., Maksemous, N., Sutherland, H. G., Lea, R. A., & Griffiths, L. R. (2025). PathVar : A Customisable NGS Variant Calling Algorithm Implicates Novel Candidate Genes and Pathways in Hemiplegic Migraine. Clinical Genetics. https://doi.org/10.1111/cge.14625
Vancouver
Alfayyadh MM, Maksemous N, Sutherland HG, Lea RA, Griffiths LR. PathVar : A Customisable NGS Variant Calling Algorithm Implicates Novel Candidate Genes and Pathways in Hemiplegic Migraine. Clinical Genetics. 2025. doi:10.1111/cge.14625
BibTeX
@article{Alfayyadh2025,
author = {Alfayyadh, Mohammed M and Maksemous, Neven and Sutherland, Heidi G and Lea, Rodney A and Griffiths, Lyn R},
title = {PathVar : A Customisable NGS Variant Calling Algorithm Implicates Novel Candidate Genes and Pathways in Hemiplegic Migraine},
journal = {Clinical Genetics},
year = {2025},
doi = {10.1111/cge.14625}
}
EUVIMED